DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
Haddenham
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Rosetta Capital VII LP | 2023 | Active deployment | $0 | $40.0M | 0 |
| Rosetta Capital VI LP | 2021 | Mature | $0 | $79.6M | 0 |
| Rosetta Capital IV LP | 2015 | Harvest | $5.2M | $58.4M | 1 |
| Roseway Capital LP | n/a | Wound down | n/a | $211,000 | 0 |
| Rosetta Capital V LP | n/a | Unknown | n/a | $29.0M | 0 |
| BML Healthcare I LP | n/a | Unknown | n/a | $5.2M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Instinctif Partners | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
Also named here, with no published line of their own (reach them through the firm): Michael Forer (Director), Jonathan Hepple (Managing Partner), Matthew James (Chief Financial Officer), Donovan Leung (Investment Manager), Namrata Turaga (Investment Manager), Sarah Laidler (Finance And Compliance Director), Jonathan Paul Hepple (Director), Graham Eric Fagg (Shareholder), Torsten Ruediger Goesch (Director).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan